Fortitude Family Office’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-824
Closed -$83.7K 1949
2025
Q4
$83.7K Sell
824
-5
-0.6% -$402 0.02% 196
2025
Q3
$45.4K Buy
829
+6
+0.7% +$300 0.01% 255
2025
Q2
$43.7K Buy
823
+23
+3% +$1.17K 0.01% 264
2025
Q1
$34.6K Hold
800
0.01% 289
2024
Q4
$45K Hold
800
0.02% 275
2024
Q3
$54.5K Hold
800
0.02% 228
2024
Q2
$33.8K Hold
800
0.02% 226
2024
Q1
$55.2K Buy
+800
New +$50.6K 0.04% 140

Other funds holding EXAS

Fortitude Family Office's EXAS Position: Q1 2026 in Review

Fortitude Family Office sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 824 shares — an estimated $83.7K sold.

Fortitude Family Office first reported a position in EXAS in Q1 2024 and held it in 8 quarters. The position peaked at $83.7K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Fortitude Family Office reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Fortitude Family Office sold 824 Exact Sciences shares in Q1 2026, an estimated $83.7K.
  • Fortitude Family Office first reported a position in Exact Sciences in Q1 2024 and held it in 8 quarters.
  • Fortitude Family Office's Exact Sciences position peaked at $83.7K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.